Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
She was the ultimate '90s fitness influencer. Now she's delivering Uber Eats — and rebuilding her life. - 25 Side interests That Work on Psychological wellness
- 3'Stranger Things' series finale trailer shows Hawkins gang gearing up for last battle with Vecna
- 4Vote in favor of your Number one method for commending a birthday
- 5RFK Jr. says fewer flu shots for kids may be 'better.' What experts say.
- The Best Games On the planet
- Instructions to Shield Your Gold Speculation from Possible Dangers: Fundamental Protections
- From Novice to Master: Dominating a Side interest
- FOX8 Meteorologist Charles Ewing makes his 2025-26 winter weather predictions!
- Experience Is standing by: History's Most noteworthy Travelers
- Vote In favor of Your Favored Language Interpretation Administration
- Tech for Wellbeing: Applications and Devices for a Better You
- The Most Compelling Books of the 10 years
- Reality TV star Spencer Pratt, who lost his home in Palisades Fire, is running for mayor of Los Angeles
